Capital Markets Day 2023
Ipsen hosted a capital-markets day on 7 December 2023, at The Brewery, London.
A replay of the event is available below.
Capital Markets Day – Webcast Replay
Speakers
As well as an opportunity to meet management, the event focused on R&D strategy, pipeline opportunities, the drivers of key on-market medicines, as well as a mid-term outlook.
IPSEN IN BRIEF
Our vision is to be a leading global mid-sized biopharmaceutical company with a focus on transformative medicines in Oncology, Rare Disease and Neuroscience.
Discover Ipsen in two pages: our medicines and key figures, our objectives and our strategy.
Should you be unable to register for the webinar due to your company IT policy, please send an e-mail to: paula.brooks@ipsen.com
Your dedicated contacts
Financial results for the first nine months of 2024
Financial results for the first half of 2024
Our 2023 Integrated Annual Report is live!
Q1 2024 sales update
Applications now open for the 2024 Golden Ticket competition
FY 2023 results announcement
Ipsen sponsors 5 elite athletes on their journeys to the 2024 Paralympics
Examining the European Pharma legislation: EFPIA publishes the Dolon Report
2023 year to date and third-quarter sales results
